Skip to content
PIL Logo

Sominex Tablets

Last Updated on eMC 17-Mar-2017 View document  | Actavis UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17-Mar-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions

Updated on 04-Aug-2015 and displayed until 17-Mar-2017

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 25-Nov-2011 and displayed until 04-Aug-2015

Reasons for adding or updating:

  • Unknown

Updated on 15-Nov-2011 and displayed until 25-Nov-2011

Reasons for adding or updating:

  • Change of manufacturer

Updated on 05-Oct-2010 and displayed until 15-Nov-2011

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions

Updated on 12-Mar-2009 and displayed until 05-Oct-2010

Reasons for adding or updating:

  • Change to packaging

Updated on 26-Sep-2008 and displayed until 12-Mar-2009

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Company image
Address

Actavis UK Ltd, a subsidiary of Accord Healthcare Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK

Fax

+44 (0)1271 346 106

Medical Information e-mail
Telephone

+44 (0)1271 385 200

Medical Information Direct Line

+44 (0)1271 385 257

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

promethazine hydrochloride

Legal categories

P - Pharmacy

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue